Publication:
SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+)/PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial

Simple item page
dc.conference.dateMAY 03-05, 2022
dc.conference.titleEuropean-Society-for-Medical-Oncology (ESMO) Breast Cancer Congress
dc.contributor.authorCiruelos, E. M.
dc.contributor.authorPonce, J.
dc.contributor.authorPernas Simon, S.
dc.contributor.authorCortes, J.
dc.contributor.authorCantos, B.
dc.contributor.authorGarate, E.
dc.contributor.authorVega Alonso, E.
dc.contributor.authorMele Olive, M.
dc.contributor.authorMartinez De Duenas, E.
dc.contributor.authorMontano Perianez, A.
dc.contributor.authorMartinez, N.
dc.contributor.authorPerello Martorell, A.
dc.contributor.authorBermejo De las Heras, B.
dc.contributor.authorArqueros Nunez, C.
dc.contributor.authorFernandez, I.
dc.contributor.authorDe la Haba Rodriguez, J.
dc.contributor.authorOliveira, M.
dc.contributor.authorGonzalez, X.
dc.contributor.authorVillagrasa Gonzalez, P.
dc.contributor.authorPrat, A.
dc.contributor.authoraffiliation[Ciruelos, E. M.] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Ciruelos, E. M.] SOLTI Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Pernas Simon, S.] SOLTI Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Ponce, J.] Hosp Gen Univ Alicante, Dept Med Oncol, Alicante, Spain
dc.contributor.authoraffiliation[Pernas Simon, S.] ICO Inst Catala Oncol, Med Oncol Breast Unit, Lhospitalet De Llobregat, Spain
dc.contributor.authoraffiliation[Cortes, J.] Int Breast Canc Ctr IBCC, Oncol Dept, Quiron Grp, Madrid, Spain
dc.contributor.authoraffiliation[Cortes, J.] Int Breast Canc Ctr IBCC, Oncol Dept, Quiron Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Cantos, B.] Univ Hosp Puerta Hierro, Dept Med Oncol, Majadahonda, Madrid, Spain
dc.contributor.authoraffiliation[Garate, E.] Hosp Univ Basurto, Dept Med Oncol, Bilbao, Spain
dc.contributor.authoraffiliation[Vega Alonso, E.] Ctr Integral Oncol Clara Campal CIOCC, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Mele Olive, M.] Hosp Univ St Joan Reus, Dept Oncol, Reus, Spain
dc.contributor.authoraffiliation[Martinez De Duenas, E.] Hosp Prov Castellon, Dept Oncol, Castellon De La Plana, Spain
dc.contributor.authoraffiliation[Montano Perianez, A.] Hosp Univ Virgen del Rocio, Dept Oncol, Seville, Spain
dc.contributor.authoraffiliation[Martinez, N.] Hosp Univ Ramon y Cajal, Dept Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Perello Martorell, A.] Hosp Univ Son Espases, Dept Oncol, Palma De Mallorca, Spain
dc.contributor.authoraffiliation[Bermejo De las Heras, B.] Hosp Clin Univ Valencia, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Arqueros Nunez, C.] Hosp Santa Creu & Sant Pau, Dept Breast Canc, Barcelona, Spain
dc.contributor.authoraffiliation[Fernandez, I.] Hosp Alvaro Cunqueiro, Dept Oncol, Vigo, Spain
dc.contributor.authoraffiliation[De la Haba Rodriguez, J.] Hosp Univ Reina Sofia, Dept Oncol, Cordoba, Spain
dc.contributor.authoraffiliation[Oliveira, M.] Vall Hebron Univ Hosp, Med Oncol Dept, Vall dHebron Inst Oncol, SOLTI Canc Res Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Gonzalez, X.] IOR Inst Oncol Dr Rosell, Oncol Dept, Barcelona, Spain
dc.contributor.authoraffiliation[Gonzalez, X.] Hosp Gen Cataluna, Sant Cugat Del Valles, Spain
dc.contributor.authoraffiliation[Gonzalez, X.] SOLTI Canc Res Grp Hosp Gen Catalunya, Barcelona, Spain
dc.contributor.authoraffiliation[Villagrasa Gonzalez, P.] SOLTI Canc Res Grp, Reveal Genom, Barcelona, Spain
dc.contributor.authoraffiliation[Prat, A.] Hosp Clin Barcelona, SOLTI Canc Res Grp, Med Oncol Dept, Barcelona, Spain
dc.date.accessioned2023-05-03T14:40:29Z
dc.date.available2023-05-03T14:40:29Z
dc.date.issued2022-05-05
dc.identifier.doi10.1016/j.annonc.2022.03.227
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753422006068/pdf
dc.identifier.urihttp://hdl.handle.net/10668/21908
dc.identifier.wosID792494100211
dc.issue.number3
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationHospital Universitario Reina Sofía
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen del Rocío
dc.page.numberS222-S223
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleSOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+)/PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number33
dc.wostypeMeeting Abstract
dspace.entity.typePublication

Files

Collections

SAS - Hospital Universitario Reina Sofía
SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía